Published in Stroke on December 08, 2011
Dabigatran etexilate for secondary stroke prevention: the first year experience from a multicenter short-term registry. Ther Adv Neurol Disord (2014) 0.79
Intravenous thrombolysis in a patient using factor Xa inhibitor. J Vasc Interv Neurol (2014) 0.75
LOWERING THE RISK FOR THROMBUS AND STROKE IN ATRIAL FIBRILLATION PATIENTS: Will Dabigatran Replace Warfarin? Clin Med Rev Vasc Health (2013) 0.75
Letter by Van de Werf et al regarding article, "using dabigatran in patients with stroke: a practical guide for clinicians". Stroke (2012) 0.75
Letter by Freeman et al regarding article, "using dabigatran in patients with stroke: a practical guide for clinicians". Stroke (2012) 0.75
The Need for a Coagulation Assay after Initiation of New Oral Anticoagulants in Patients with Renal Dysfunction: A Case Report. J Clin Neurol (2014) 0.75
Tissue plasminogen activator; identifying major barriers related to intravenous injection in ischemic acute cerebral infraction. J Res Med Sci (2017) 0.75
Letter by Casado-Naranjo et al regarding article, "using dabigatran in patients with stroke: a practical guide for clinicians". Stroke (2012) 0.75
Choking the Feeder. Indian J Nephrol (2017) 0.75
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med (2015) 10.86
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol (2012) 5.91
Idarucizumab for Dabigatran Reversal. N Engl J Med (2015) 5.91
Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med (2014) 5.44
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med (2012) 3.16
Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA (2010) 2.68
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Cardiovasc Electrophysiol (2002) 2.14
The Food and Drug Administration decision not to approve the 110 mg dose of dabigatran: give us a way out. Am J Med (2012) 2.08
Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke (2009) 1.96
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol (2012) 1.85
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood (2009) 1.84
Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin. J Gen Intern Med (2009) 1.77
Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am Heart J (2010) 1.76
A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm (2007) 1.61
Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage. Neurocrit Care (2012) 1.55
Endovascular stroke therapy: a single-center retrospective review. Neurosurg Focus (2011) 1.44
Amplification of acute focal ischemic deficit by narcotics. Neurocrit Care (2008) 1.44
Ictal sensory periodic lateralized epileptiform discharges. Epilepsy Behav (2011) 1.40
Left ventricular aneurysm as a consequence of hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv (2002) 1.39
Surgical management of endocarditis: the society of thoracic surgeons clinical practice guideline. Ann Thorac Surg (2011) 1.36
Postpartum angiopathy and other cerebral vasoconstriction syndromes. Neurocrit Care (2005) 1.35
Endovascular stenting of extracranial carotid and vertebral artery dissections: a systematic review of the literature. Neurosurgery (2011) 1.29
Exploring the generalist-subspecialist interface in internal medicine. Am J Med (2006) 1.17
Practice patterns among United States cardiologists for managing adults with atrial fibrillation (from the AFFECTS Registry). Am J Cardiol (2010) 1.11
Reduced platelet activity is associated with more intraventricular hemorrhage. Neurosurgery (2009) 1.05
Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. Arch Neurol (2005) 1.03
NASPE training requirements for cardiac implantable electronic devices: selection, implantation, and follow-up. Pacing Clin Electrophysiol (2003) 0.96
Leukoaraiosis on magnetic resonance imaging correlates with worse outcomes after spontaneous intracerebral hemorrhage. Stroke (2013) 0.95
How patients die after intracerebral hemorrhage. Neurocrit Care (2009) 0.95
Complications of biventricular pacing. Curr Opin Cardiol (2004) 0.94
Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm (2004) 0.93
How I treat target-specific oral anticoagulant-associated bleeding. Blood (2014) 0.91
The novel oral anticoagulants. Semin Thromb Hemost (2013) 0.91
Rupture of cerebral myxomatous aneurysm months after resection of the primary cardiac tumor. Neurocrit Care (2010) 0.90
Platelet activity and outcome after intracerebral hemorrhage. Ann Neurol (2009) 0.90
Aspirin use or reduced platelet activity predicts craniotomy after intracerebral hemorrhage. Neurocrit Care (2011) 0.90
Oral clopidogrel load in aspirin-resistant capsular warning syndrome. Neurocrit Care (2005) 0.89
Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry). Am J Cardiol (2010) 0.88
Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care (2010) 0.87
Classification of cerebral infarction after subarachnoid hemorrhage impacts outcome. Neurosurgery (2009) 0.87
Fast-track training of nonelectrophysiologists to implant defibrillators: is it needed? Pacing Clin Electrophysiol (2006) 0.87
Intracardiac echocardiography in complex cardiac catheter ablation procedures. J Interv Card Electrophysiol (2010) 0.86
Capital breeding and allocation to life-history demands are highly plastic in lizards. Am Nat (2012) 0.86
Atrial fibrillation in patients with heart failure. Curr Opin Cardiol (2003) 0.86
Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study. Am Heart J (2009) 0.86
Task force 6: training in specialized electrophysiology, cardiac pacing, and arrhythmia management endorsed by the Heart Rhythm Society. J Am Coll Cardiol (2008) 0.85
Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials. Curr Opin Cardiol (2002) 0.85
Severe reversible cerebral vasoconstriction syndrome mimicking aneurysmal rupture and vasospasm. Neurocrit Care (2007) 0.85
Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter. J Interv Card Electrophysiol (2008) 0.85
Symptomatic spontaneous intracranial carotid artery dissection treated with a self-expanding intracranial nitinol stent: a case report. Surg Neurol (2008) 0.85
Quantitative cerebral MR perfusion imaging: preliminary results in stroke. J Magn Reson Imaging (2010) 0.84
Fever burden and functional recovery after subarachnoid hemorrhage. Neurosurgery (2008) 0.84
Role of intracardiac ultrasound in interventional electrophysiology. Curr Opin Cardiol (2004) 0.84
A survey of oral vitamin K use by anticoagulation clinics. Arch Intern Med (2002) 0.83
Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections. Cerebrovasc Dis (2014) 0.82
Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin. N Engl J Med (2003) 0.82
Management of atrial fibrillation: translating clinical trial data into clinical practice. Am J Med (2011) 0.82
Oral antiplatelet therapy. JAMA (2005) 0.82
Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility. Blood (2011) 0.81
Task Force 6: training in specialized electrophysiology, cardiac pacing, and arrhythmia management: endorsed by the Heart Rhythm Society. J Am Coll Cardiol (2006) 0.81
Clinical significance of increased tricuspid valve incompetence following implantation of ventricular leads. J Interv Card Electrophysiol (2013) 0.80
Use of Conivaptan (Vaprisol) for hyponatremic neuro-ICU patients. Neurocrit Care (2010) 0.79
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. J Cardiovasc Electrophysiol (2011) 0.79
Nonadherence with INR monitoring and anticoagulant complications. Thromb Res (2013) 0.79
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil. J Thromb Thrombolysis (2011) 0.79
The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS. Curr Cardiol Rev (2014) 0.78
Anticoagulation, novel agents, and procedures: can we pardon the interruption? Circulation (2012) 0.78
Letter by Bernstein et al regarding article, "reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation (2012) 0.78
Antiarrhythmic drug therapy for atrial fibrillation: are the guidelines guiding clinical practice? Clin Cardiol (2006) 0.78
Duration of anticoagulation after cerebral venous sinus thrombosis. Neurocrit Care (2012) 0.78
Clinical efficacy of dofetilide for the treatment of atrial tachyarrhythmias in adults with congenital heart disease. Congenit Heart Dis (2013) 0.78
A review of the pharmacokinetics, electrophysiology and clinical efficacy of dronedarone. Future Cardiol (2005) 0.78
The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need for clinical education. Crit Pathw Cardiol (2010) 0.78
Entrainment of ventricular tachycardia with a permanent biventricular pacemaker. J Interv Card Electrophysiol (2002) 0.78
Reversal of diffusion restriction after embolization of dural arteriovenous fistula: case report. Neurosurgery (2010) 0.77
Warfarin pharmacogenetics. N Engl J Med (2009) 0.77
Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum. Ann Pharmacother (2013) 0.76
Reduced platelet activity is more common than reported anti-platelet medication use in patients with intracerebral hemorrhage. Neurocrit Care (2009) 0.76
Pathophysiology and disease progression of atrial fibrillation: importance of achieving and maintaining sinus rhythm. J Cardiovasc Electrophysiol (2008) 0.76
Hyperglycemia and insulin resistance in cardiac arrest patients treated with moderate hypothermia. J Clin Endocrinol Metab (2014) 0.75
Device therapies in the post-myocardial infarction patient with left ventricular dysfunction. Am J Cardiol (2008) 0.75
The reply. Am J Med (2013) 0.75
Can we predict antiarrhythmic efficacy or inefficacy of amiodarone or any other antiarrhythmic? What this patient needs is a doctor! J Cardiovasc Electrophysiol (2004) 0.75
Ambulatory electrocardiographic monitoring: has mobile cardiac outpatient telemetry changed the playing field? J Cardiovasc Electrophysiol (2007) 0.75
Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry. J Cardiovasc Electrophysiol (2006) 0.75
Use of dipyridamole in patients with recent stroke or TIA. Am Fam Physician (2005) 0.75
Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH 2. Neurology (2010) 0.75
In people with atrial fibrillation unsuitable for warfarin, apixaban reduces the risk of stroke compared with aspirin, with no difference in major bleeding. Evid Based Med (2011) 0.75
Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology (2011) 0.75
Transient ischemic attack--proposed new definition. N Engl J Med (2003) 0.75
Selection of drugs in pursuit of rate control strategy. Prog Cardiovasc Dis (2005) 0.75
Biventricular pacing in congestive heart failure: a boost toward finer living. Curr Opin Cardiol (2002) 0.75
Working group 1: How to increase the output of cardiologists. J Am Coll Cardiol (2004) 0.75
Paroxysmal atrioventricular block following a ventricular premature beat. J Cardiovasc Electrophysiol (2007) 0.75
Are new oral anticoagulants ready for use in patients with cancer? J Natl Compr Canc Netw (2013) 0.75